Physician profile
Deepthi Deconda
NPI 1477727451
$2,429.38
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.28 · 2022: $386 · 2023: $792 · 2024: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959 · Education: $34.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.60 |
| Education | $34.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $869.14 | 2022-2024 | Linzess, Viberzi, Creon |
| Phathom Pharmaceuticals, INC. | $255.22 | 2024 | Voquezna |
| Janssen Biotech, INC. | $208.57 | 2023-2024 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $141.24 | 2022-2024 | Xifaxan |
| Genzyme Corporation | $139.67 | 2023-2024 | |
| Ardelyx, INC. | $131.75 | 2023-2024 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $112.09 | 2023-2024 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $101.14 | 2024 | Dupixent |
| Boston Scientific Corporation | $89.67 | 2022 | |
| Celgene Corporation | $58.26 | 2024 | Zeposia |
| Covidien Lp | $50.28 | 2020 | |
| Nestle Healthcare Nutrition INC. | $49.06 | 2023 | |
| Gilead Sciences, INC. | $39.84 | 2024 | |
| Lilly USA, LLC | $39.77 | 2024 | Omvoh |
| Celltrion USA INC. | $34.83 | 2024 | Zymfentra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $27.61 | 2024 | |
| Ferring Pharmaceuticals INC. | $19.16 | 2024 | Rebyota |
| Ironwood Pharmaceuticals, INC | $16.33 | 2023 | Linzess |
| Conmed Corporation | $15.99 | 2023 | Conmed Hemostasis |
| Aimmune Therapeutics, INC. | $15.67 | 2024 | |
| Organon LLC | $14.09 | 2023 | Renflexis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepthi Deconda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.